| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Omega Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 110,000 | 07 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OMGA | Omega Therapeutics, Inc. | 07 Feb 2024 | 1 | $0 | 4 | Chief Medical Officer | 09 Feb 2024, 16:59 |
| OMGA | Omega Therapeutics, Inc. | 28 Feb 2023 | 1 | $0 | 4 | Chief Medical Officer | 02 Mar 2023, 15:05 |
| OMGA | Omega Therapeutics, Inc. | 27 Oct 2022 | 1 | $0 | 4 | Chief Medical Officer | 28 Oct 2022, 18:38 |
| OMGA | Omega Therapeutics, Inc. | 31 Jan 2022 | 1 | $0 | 4 | Chief Medical Officer | 02 Feb 2022, 15:05 |
| OMGA | Omega Therapeutics, Inc. | 03 Jan 2022 | 0 | $0 | 3 | Chief Medical Officer | 06 Jan 2022, 15:15 |